Hologic Inc logo

HOLX - Hologic Inc Share Price

$76.86 2.4  3.3%

Last Trade - 3:16pm

Large Cap
Market Cap £13.96bn
Enterprise Value £15.35bn
Revenue £3.30bn
Position in Universe 597th / 6841
Unlock HOLX Revenue
Relative Strength (%)
1m +1.07%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -12.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 26th Sep 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
2,705 2,833 3,059 3,218 3,367 3,776 5,661 4,434 +6.9%
+141.5 +74.3 -37.8 -72.2 +349.6 +363 +101.5 -42.0
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 26 December 2020, Hologic, Inc. revenues increased 89% to $1.61B. Net incomeincreased 69% to $654.4M. Revenues reflect Diagnosticssegment increase from $311.5M to $1.13B, GYN Surgicalsegment increase of 4% to $124M, Breast Health segmentincrease of less than 1% to $332.7M. Net income waspartially offset by GYN Surgical segment income decrease of57% to $13.7M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for HOLX
Graphical History


HOLX Revenue Unlock HOLX Revenue

Net Income

HOLX Net Income Unlock HOLX Revenue

Normalised EPS

HOLX Normalised EPS Unlock HOLX Revenue

PE Ratio Range

HOLX PE Ratio Range Unlock HOLX Revenue

Dividend Yield Range

HOLX Dividend Yield Range Unlock HOLX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
HOLX EPS Forecasts Unlock HOLX Revenue
Profile Summary

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.

Last Annual September 26th, 2020
Last Interim December 26th, 2020
Incorporated January 18, 1990
Public Since March 1, 1990
No. of Shareholders: 930
No. of Employees: 5,814
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite , S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange NASDAQ Global Select Market
Shares in Issue 257,661,792
Free Float (0.0%)
Eligible for
HOLX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for HOLX
Upcoming Events for HOLX
Wednesday 28th April, 2021
Q2 2021 Hologic Inc Earnings Release
Wednesday 28th April, 2021
Q2 2021 Hologic Inc Earnings Call
Tuesday 27th July, 2021 Estimate
Q3 2021 Hologic Inc Earnings Release
Frequently Asked Questions for Hologic Inc
What is the Hologic Inc share price?

As of 3:16pm, shares in Hologic Inc are trading at $76.86, giving the company a market capitalisation of £13.96bn. This share price information is delayed by 15 minutes.

How has the Hologic Inc share price performed this year?

Shares in Hologic Inc are currently trading at $76.86 and the price has moved by 81.03% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Hologic Inc price has moved by 21.08% over the past year.

What are the analyst and broker recommendations for Hologic Inc?

Of the analysts with advisory recommendations for Hologic Inc, there are there are currently 7 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Hologic Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Hologic Inc next release its financial results?

Hologic Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-26
What is the Hologic Inc dividend yield?

Hologic Inc does not currently pay a dividend.

Does Hologic Inc pay a dividend?

Hologic Inc does not currently pay a dividend.

When does Hologic Inc next pay dividends?

Hologic Inc does not currently pay a dividend.

How do I buy Hologic Inc shares?

To buy shares in Hologic Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Hologic Inc?

Shares in Hologic Inc are currently trading at $76.86, giving the company a market capitalisation of £13.96bn.

Where are Hologic Inc shares listed? Where are Hologic Inc shares listed?

Here are the trading details for Hologic Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: HOLX
What kind of share is Hologic Inc?

Based on an overall assessment of its quality, value and momentum, Hologic Inc is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Hologic Inc share price forecast 2021?

Shares in Hologic Inc are currently priced at $76.86. At that level they are trading at 19.28% discount to the analyst consensus target price of 0.00.

Analysts covering Hologic Inc currently have a consensus Earnings Per Share (EPS) forecast of 8.716 for the next financial year.

How can I tell whether the Hologic Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hologic Inc. Over the past six months, the relative strength of its shares against the market has been -5.59%. At the current price of $76.86, shares in Hologic Inc are trading at 6.8% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Hologic Inc PE Ratio?

The Hologic Inc PE ratio based on its reported earnings over the past 12 months is 13.82. The shares are currently trading at $76.86.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Hologic Inc?

Hologic Inc's management team is headed by:

Sally Crawford - LED
Scott Garrett - IND
Stephen Macmillan - CHM
John Griffin - GCN
Charles Dockendorff - IND
Namal Nawana - IND
Allison Bebo - SVP
Karleen Oberton - CFO
Ludwig Hantson - IND
Kevin Thornal - CEX
Who are the major shareholders of Hologic Inc?

Here are the top five shareholders of Hologic Inc based on the size of their shareholding:

T. Rowe Price Associates, Inc. Investment Advisor
Percentage owned: 15.24% (39.3m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 10.69% (27.5m shares)
Fidelity Management & Research Company LLC Investment Advisor
Percentage owned: 9.8% (25.2m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.86% (15.1m shares)
T. Rowe Price Mid-Cap Growth Fund Mutual Fund
Percentage owned: 5.24% (13.5m shares)
Similar to HOLX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.